Cargando…
Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis
Disease-modifying therapies in both light chain and transthyretin amyloidosis have improved patient functional status and survival. Conceivably, as heart failure may progress despite amyloid therapies, more patients may be considered for heart transplantation. In earlier eras, extra-cardiac amyloid...
Autores principales: | Punnoose, Lynn Raju, Siddiqi, Hasan, Rosenthal, Julie L, Kittleson, Michelle, Witteles, Ronald, Alexander, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987512/ https://www.ncbi.nlm.nih.gov/pubmed/36891177 http://dx.doi.org/10.15420/cfr.2022.24 |
Ejemplares similares
-
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group
por: Maurer, Mathew S., et al.
Publicado: (2022) -
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014) -
Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018) -
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022) -
Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
por: Roger-Rollé, Aénora, et al.
Publicado: (2020)